English 
From Genomics to Generative AI: Japan’s Bold Step in Personalized Medicine
The planet can no longer treat all people alike. Universal healthcare system is no longer a viable option, particularly in Japan where the aging populace is pushing the necessity of smarter and more accurate medical care. Personalized medicine is a panacea, adjusting medications to every patient's distinct genetic and biological characteristic. Japan is very well placed to navigate this transformation. The country is creating a mix of biology and computation that few other places in the world can do, with large-scale national genomic databases and increasing proficiency in generative AI. AMED is at the center of this push, funding projects that blend multiple research areas, from drug development to regenerative medicine. In 2025, AMED’s programs included large calls like SATREPS, symposia on topics such as Proteostasis, and cross-ministerial initiatives that…
日本語